STATE STREET CORP - FINCH THERAPEUTICS GROUP INC ownership

FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 54 filers reported holding FINCH THERAPEUTICS GROUP INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of FINCH THERAPEUTICS GROUP INC
ValueSharesWeighting
Q1 2023$9,620
-59.1%
24,479
-50.0%
0.00%
Q4 2022$23,500
-42.7%
48,958
+100.0%
0.00%
Q3 2022$41,000
-41.4%
24,4790.0%0.00%
Q2 2022$70,000
-87.2%
24,479
-77.6%
0.00%
Q1 2022$549,000
-48.2%
109,194
+2.8%
0.00%
Q4 2021$1,059,000
-22.0%
106,219
+1.7%
0.00%
Q3 2021$1,357,000
+35.8%
104,412
+47.0%
0.00%
Q2 2021$999,00071,0180.00%
Other shareholders
FINCH THERAPEUTICS GROUP INC shareholders Q1 2022
NameSharesValueWeighting ↓
Avenir Management Company, LLC 1,663,366$653,7033.23%
Bleichroeder LP 810,416$318,4930.07%
Ikarian Capital, LLC 237,553$93,3590.02%
LAKE STREET ADVISORS GROUP, LLC 739,136$2910.02%
Baupost Group 2,019,008$7930.01%
Proficio Capital Partners LLC 110,559$43,4500.01%
MSD Partners, L.P. 153,397$60,2850.01%
Ballentine Partners, LLC 143,603$56,4360.00%
SVB WEALTH LLC 253,054$99,4500.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 18,783$7,3820.00%
View complete list of FINCH THERAPEUTICS GROUP INC shareholders